0001214659-20-000663.txt : 20200129
0001214659-20-000663.hdr.sgml : 20200129
20200129163017
ACCESSION NUMBER: 0001214659-20-000663
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200128
FILED AS OF DATE: 20200129
DATE AS OF CHANGE: 20200129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Durrant Cameron
CENTRAL INDEX KEY: 0001421882
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35798
FILM NUMBER: 20558535
MAIL ADDRESS:
STREET 1: 90, FAIRMOUNT ROAD WEST
CITY: CALIFON
STATE: NJ
ZIP: 07830-3330
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HUMANIGEN, INC
CENTRAL INDEX KEY: 0001293310
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770557236
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 533 AIRPORT BLVD.
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 650.243.3100
MAIL ADDRESS:
STREET 1: 533 AIRPORT BLVD.
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
FORMER COMPANY:
FORMER CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20040609
4
1
marketforms-47580.xml
PRIMARY DOCUMENT
X0306
4
2020-01-28
0001293310
HUMANIGEN, INC
HGEN
0001421882
Durrant Cameron
C/O HUMANIGEN, INC.
533 AIRPORT BOULEVARD, SUITE 400
BURLINGAME
CA
94010
true
true
false
false
Chief Executive Officer
Stock Option (Right to Buy)
0.40
2020-01-28
4
A
false
318103
0.40
A
2020-01-28
2030-01-27
Common Stock
318103
318103
D
These stock options were granted in lieu of a portion of the cash bonus payable to Dr. Durrant in respect of his services as Chief Executive Officer in 2019.
/s/ Cameron Durrant
2020-01-29